Drug class · Oncology & immunology
Kinase inhibitors
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| everolimus | Everolimus 5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-031 |
| everolimus | Everolimus 10 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-033 |
| everolimus | Everolimus 1 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-934 |
| everolimus | Everolimus .25 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-931 |
| everolimus | Everolimus .5 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-932 |
| everolimus | Everolimus .75 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-933 |
| imatinib mesylate | Imatinib mesylate 100 mg/1 | Tablet, Film coatedOral | BluePoint Laboratories | 68001-490 |
| imatinib mesylate | Imatinib mesylate 400 mg/1 | Tablet, Film coatedOral | BluePoint Laboratories | 68001-491 |
| imatinib mesylate | Imatinib mesylate 100 mg/1 | TabletOral | Archis Pharma LLC | 72819-185 |
| imatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | Archis Pharma LLC | 72819-186 |
| imatinib mesylate | Imatinib mesylate 100 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 47335-472 |
| imatinib mesylate | Imatinib mesylate 400 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 47335-475 |
| imatinib mesylate | Imatinib mesylate 100 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0832-0532 |
| imatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0832-0533 |
| imatinib mesylate | Imatinib mesylate 100 mg/1 | TabletOral | Qilu Pharmaceutical Co., Ltd. | 67184-0532 |
| imatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | Qilu Pharmaceutical Co., Ltd. | 67184-0533 |
| nilotinib | Nilotinib 200 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-239 |
| nilotinib | Nilotinib 50 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-237 |
| nilotinib | Nilotinib 150 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-238 |
| nilotinib | Nilotinib 150 mg/1 | CapsuleOral | AvKARE | 73190-033 |
| nilotinib | Nilotinib 200 mg/1 | CapsuleOral | AvKARE | 73190-034 |
| nilotinib | Nilotinib hydrochloride monohydrate 200 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-711 |
| nilotinib | Nilotinib hydrochloride monohydrate 150 mg/1 | CapsuleOral | Torrent Pharmaceuticals Limited | 13668-710 |
| nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Sandoz Inc | 0781-2492 |
| nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Sandoz Inc | 0781-2495 |